Integrative pan-cancer genomic analysis highlights mitochondrial protein p32 as a potential therapeutic target in Myc-driven tumorigenesis.
Saved in:
| Title: | Integrative pan-cancer genomic analysis highlights mitochondrial protein p32 as a potential therapeutic target in Myc-driven tumorigenesis. |
|---|---|
| Authors: | Bi Q; Cancer Institute, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221004, Jiangsu, China.; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, China., Nie J; Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China., Wu Q; Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Road, Wuhan, 430022, China., Sun L; Cancer Institute, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221004, Jiangsu, China., Zhu S; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, China., Bai J; Cancer Institute, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221004, Jiangsu, China. bj@xzhmu.edu.cn.; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221004, Jiangsu, China. bj@xzhmu.edu.cn., Liu Y; Cancer Institute, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221004, Jiangsu, China. liuymito@xzhmu.edu.cn.; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221004, Jiangsu, China. liuymito@xzhmu.edu.cn., Huang F; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, China. 2022XH0002@hust.edu.cn.; Hubei Key Laboratory of Precision Radiation Oncology, Wuhan, China. 2022XH0002@hust.edu.cn., Chai K; Cancer Institute, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221004, Jiangsu, China. kelichai@xzhmu.edu.cn.; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221004, Jiangsu, China. kelichai@xzhmu.edu.cn. |
| Source: | Medical oncology (Northwood, London, England) [Med Oncol] 2025 Feb 01; Vol. 42 (3), pp. 60. Date of Electronic Publication: 2025 Feb 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-131X (Electronic) Linking ISSN: 13570560 NLM ISO Abbreviation: Med Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39891862 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Integrative pan-cancer genomic analysis highlights mitochondrial protein p32 as a potential therapeutic target in Myc-driven tumorigenesis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Bi+Q%22">Bi Q</searchLink>; Cancer Institute, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221004, Jiangsu, China.; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, China.<br /><searchLink fieldCode="AU" term="%22Nie+J%22">Nie J</searchLink>; Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.<br /><searchLink fieldCode="AU" term="%22Wu+Q%22">Wu Q</searchLink>; Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Road, Wuhan, 430022, China.<br /><searchLink fieldCode="AU" term="%22Sun+L%22">Sun L</searchLink>; Cancer Institute, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221004, Jiangsu, China.<br /><searchLink fieldCode="AU" term="%22Zhu+S%22">Zhu S</searchLink>; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, China.<br /><searchLink fieldCode="AU" term="%22Bai+J%22">Bai J</searchLink>; Cancer Institute, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221004, Jiangsu, China. bj@xzhmu.edu.cn.; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221004, Jiangsu, China. bj@xzhmu.edu.cn.<br /><searchLink fieldCode="AU" term="%22Liu+Y%22">Liu Y</searchLink>; Cancer Institute, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221004, Jiangsu, China. liuymito@xzhmu.edu.cn.; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221004, Jiangsu, China. liuymito@xzhmu.edu.cn.<br /><searchLink fieldCode="AU" term="%22Huang+F%22">Huang F</searchLink>; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, China. 2022XH0002@hust.edu.cn.; Hubei Key Laboratory of Precision Radiation Oncology, Wuhan, China. 2022XH0002@hust.edu.cn.<br /><searchLink fieldCode="AU" term="%22Chai+K%22">Chai K</searchLink>; Cancer Institute, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221004, Jiangsu, China. kelichai@xzhmu.edu.cn.; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221004, Jiangsu, China. kelichai@xzhmu.edu.cn. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229435512%22">Medical oncology (Northwood, London, England)</searchLink> [Med Oncol] 2025 Feb 01; Vol. 42 (3), pp. 60. <i>Date of Electronic Publication: </i>2025 Feb 01. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9435512 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1559-131X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213570560%22">13570560 </searchLink><i>NLM ISO Abbreviation: </i>Med Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39891862 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s12032-025-02604-9 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 60 Titles: – TitleFull: Integrative pan-cancer genomic analysis highlights mitochondrial protein p32 as a potential therapeutic target in Myc-driven tumorigenesis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bi Q – PersonEntity: Name: NameFull: Nie J – PersonEntity: Name: NameFull: Wu Q – PersonEntity: Name: NameFull: Sun L – PersonEntity: Name: NameFull: Zhu S – PersonEntity: Name: NameFull: Bai J – PersonEntity: Name: NameFull: Liu Y – PersonEntity: Name: NameFull: Huang F – PersonEntity: Name: NameFull: Chai K IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2025 Feb 01 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1559-131X Numbering: – Type: volume Value: 42 – Type: issue Value: 3 Titles: – TitleFull: Medical oncology (Northwood, London, England) Type: main |
| ResultId | 1 |